switching from dulaglutide to semaglutide Between Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance No Difference Seen in Risk

Nurse practitioners (NPs) and physician assistants (PAs) may prescribe semaglutide in states where their scope of practice permits independent prescribing or prescribing under physician oversight

For instance, 55% of employers cover GLP-1s for diabetes , but just 36% of companies cover these drugs for weight loss

They were able to do the synthesis by joining just two peptide fragments with an enzyme, omniligase-1, which catalyses amide bond formation, using fewer steps than most other methods

This Proof Points edition was originally published on LinkedIn on 11/21/23.

Hashimoto S, Gamage U, Inoue Y, et al

FDA filing is expected 20252026